First of all, zolpidem certainly isnt a nootropic in the traditional sense, nor a normal supplement, so no idea what section would be the most apropiate to discuss this, nonetheless zolpidem seems to have some interesting potential in cases of brain injury wich i tought was worth discussing.
Wikipedia:
Brain injury
A case study performed at the Toulouse University Hospital using PET showed zolpidem repeatably improves brain function and mobility of a patient immobilized by akinetic mutism caused by hypoxia.[19]
Recently, zolpidem has been cited in various medical reports mainly in the United Kingdom as waking persistent vegetative state (PVS) patients, and dramatically improving the conditions of people with brain injuries.[20][21][22][23][24] Results from phase IIa trials were expected in June 2007. The trials are being conducted by Regen Therapeutics of the UK, who have a patent pending on this new use for Zolpidem.[25][26]
[edit]Coma
Zolpidem has recently been very strongly related to certain instances of patients in a minimally conscious state being brought to a fully conscious state. While it was initially given to these patients to put them to sleep, it actually brought them to a fully conscious state in which they were capable of communicating and interacting for the first time in years. SPECT and PET scans have shown that the use of the drug actually does dramatically increase the activity in areas of the brain in some patients in a minimally conscious state. Large-scale studies are currently being done to see whether it has the same universal effect on all or most patients in a minimally conscious state.[27] It may be that zolpidem's ability to stimulate the brain, particularly in the semi-comatose, may be related to one of its side-effects, which sometimes causes sleepwalking and other activity while asleep, that appears to observers to be fully conscious activity.
Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy.
Brefel-Courbon C, Payoux P, Ory F, Sommet A, Slaoui T, Raboyeau G, Lemesle B, Puel M, Montastruc JL, Demonet JF, Cardebat D.
Department of Pharmacology and Centre Midi-Pyrenees de Pharmacovigilance, de Pharmacoepidemiologie et d'Informations sur le Medicament, Faculty of Medecine, University Toulouse, 37 allées Jules Guesde, 31000 Toulouse, France. brefel@cict.fr
Comment in:
Ann Neurol. 2007 Jul;62(1):5-7.
Ann Neurol. 2008 Oct;64(4):477-8.
Abstract
We conducted a randomized, double-blind, placebo-controlled, single-patient (N = 1) trial to evaluate the efficacy of zolpidem in a 48-year-old woman with an akinetic mutism. Motor and cognitive examinations and functional imaging were performed. Acute administration of zolpidem markedly improved motor performance and neuropsychological status. Cerebral metabolism ((18)F-fluorodeoxyglucose positron emission tomography) increased in postrolandic territories and in frontal cortex. Using the H(2) (15)O positron emission tomography, we found a drug-induced activation in the anterior cingulate and orbitofrontal cortices. Zolpidem induced a transient improvement in motor and cognitive performances. This paradoxical effect could result from an activation of limbic loops modulating motivational processes.
S Afr Med J. 2000 Jan;90(1):68-72.
Extraordinary arousal from semi-comatose state on zolpidem. A case report.
Clauss RP, Güldenpfennig WM, Nel HW, Sathekge MM, Venkannagari RR.
Department of Nuclear Medicine, Medical University of Southern Africa, Medunsa.
Abstract
A young semi-comatose male patient was investigated using 99mTc hexamethyl-propylene amine oxime (99mTc HMPAO) brain single photon emission computed tomography (SPECT) before and after administration of the gamma-aminobutyric acid (GABA) agonist zolpidem. It was observed that 15 minutes after application of the drug the patient awoke from his semi-comatose condition and remained awake for the next 3-4 hours. When drug action subsided he returned to his semi-comatose state. Brain SPECT before drug application showed large hypo-active areas in certain parts of the brain. Brain SPECT after drug application showed a generalised cortical activation relative to the cerebellum and a marked and amplified activation of the areas that were hypo-active before drug application.
And a few articles:
http://news.bbc.co.u...lth/5008744.stm
http://www.guardian....lthandwellbeing
http://www.guardian....lth.humanrights
http://abcnews.go.co...=2947406&page=1
I quickly took all those links and abstracts from wikipedia, i'm not sure wheter any new evidence has showed up, or more information about its mechanism of action, i was pretty impressed by those findings, will take a look on pubmed one of the days for some more data.
Edited by medievil, 02 September 2010 - 11:27 PM.